Thiotepa (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Thiotepa drug offered from Sagent Pharmaceuticals. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | Thiotepa |
| SUBSTANCE NAME: | THIOTEPA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRACAVITARY; INTRAVENOUS; INTRAVESICAL |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-15 |
| END MARKETING DATE: | 0000-00-00 |
Thiotepa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Thiotepa from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1.5mL) |
| START MARKETING DATE: | 2017-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-246_a3ae11de-edf2-4750-bb92-efd6ae81af70 |
| PRODUCT NDC: | 25021-246 |
| APPLICATION NUMBER: | ANDA209150 |
Other THIOTEPA Pharmaceutical Manufacturers / Labelers:
